Radiographic and Pain Outcomes from a Phase 3 Extension Study Evaluating the Safety and Efficacy of Lorecivivint in Subjects with Severe Osteoarthritis of the Knee (OA-07): 36 Month Single Blind and Placebo Crossover Phase Results

被引:0
|
作者
Yazici, Yusuf [1 ]
Swearingen, Christopher [2 ]
Lopez, Victor [3 ]
Britt, Jon [4 ]
Kennedy, Sarah [5 ]
Tambiah, Jeyanesh [2 ]
McAlindon, Timothy [6 ]
机构
[1] NYU Grossman Sch Med, La Jolla, CA USA
[2] Biosplice Therapeut Inc, San Diego, CA USA
[3] Biosplice Therapeut Inc, Santa Clarita, CA USA
[4] Biosplice Therapeut Inc, Los Angeles, CA USA
[5] Biosplice Therapeut Inc, Superior, CO USA
[6] Tufts Med Ctr, Arlington, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0820
引用
收藏
页码:1642 / 1644
页数:3
相关论文
共 50 条
  • [31] Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study
    Cai, L.
    Gu, J.
    Zheng, J.
    Zheng, M.
    Wang, G.
    Xi, L. -Y.
    Hao, F.
    Liu, X. -M.
    Sun, Q. -N.
    Wang, Y.
    Lai, W.
    Fang, H.
    Tu, Y. -T.
    Sun, Q.
    Chen, J.
    Gao, X. -H.
    Gu, Y.
    Teixeira, H. D.
    Zhang, J. -Z.
    Okun, M. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 89 - 95
  • [32] Advance Outcomes - A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in Subjects with Pulmonary Arterial Hypertension
    Channick, R.
    Tapson, V. F.
    Humbert, M.
    Deng, C.
    Escudero, M.
    Grover, R.
    Solum, D. T.
    McLaughlin, V. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA IN THE TREATMENT OF UPPER FACIAL LINES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY
    Kerscher, Martina
    Rzany, Berthold
    Prager, Welf
    Trevidic, Patrick
    Inglefield, Christopher
    TOXICON, 2018, 156 : S60 - S60
  • [34] Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study
    Afilalo, Marc
    Etropolski, Mila S.
    Kuperwasser, Brigitte
    Kelly, Kathy
    Okamoto, Akiko
    Van Hove, Ilse
    Steup, Achim
    Lange, Bernd
    Rauschkolb, Christine
    Haeussler, Juergen
    CLINICAL DRUG INVESTIGATION, 2010, 30 (08) : 489 - 505
  • [35] Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: Results from the placebo-controlled portion of a phase II, randomized, double-blind study
    Kimball, A.
    Jemec, G.
    Okun, M.
    Gu, Y.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB155 - AB155
  • [36] Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study
    Seok, Joon
    Koh, Young Gue
    Hong, Jun Ki
    Yun, So Hye
    Kim, Da Hye
    Son, Hyung Seok
    Choi, Sun Young
    Yoo, Kwang Ho
    Lee, Yang Won
    Kim, Beom Joon
    DERMATOLOGIC SURGERY, 2024, 50 (06) : 527 - 533
  • [37] Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: results from the placebo-controlled portion of a phase II, randomized, double-blind study
    Kimball, A. B.
    Jemec, G.
    Gu, Y.
    Okun, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 6 - 6
  • [38] A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in Subjects with Pulmonary Arterial Hypertension (ADVANCE OUTCOMES)
    Mclaughlin, V. V.
    Channick, R. N.
    Deng, C.
    Escudero, M.
    Grover, R.
    Solum, D. T.
    Humbert, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [39] Efficacy and Safety of AXS-07 (MoSEICT Meloxicam/Rizatriptan) in the Acute Treatment of Migraine: Results from the INTERCEPT Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    Jones, Amanda
    O'Gorman, Cedric
    Tepper, Stewart J.
    Lipton, Richard B.
    Tabuteau, Herriot
    ANNALS OF NEUROLOGY, 2020, 88 : S150 - S151
  • [40] Efficacy and safety of AXS-07 (MoSEICT Meloxicam/Rizatriptan) in the acute treatment of migraine: Results from the INTERCEPT phase 3 randomized, double-blind, placebo-controlled trial
    Jones, A.
    O'Gorman, C.
    Tepper, S. J.
    Lipton, R. B.
    Tabuteau, H.
    HEADACHE, 2021, 61 : 103 - 103